These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2374490)

  • 1. Is the detection of fucose cancer markers by 2D 1H NMR unequivocal?
    Phillips PS; Herring FG
    Magn Reson Med; 1990 Jul; 15(1):1-7. PubMed ID: 2374490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional 1H NMR spectroscopy of normal and pathological human plasma: complete water suppression and further assignment of resonances.
    Kriat M; Confort-Gouny S; Vion-Dury J; Viout P; Cozzone PJ
    Biochimie; 1992; 74(9-10):913-8. PubMed ID: 1334700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells.
    Lean CL; Mackinnon WB; Mountford CE
    Magn Reson Med; 1991 Aug; 20(2):306-11. PubMed ID: 1775056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of lactate, threonine and alanine in rat thymus and tumorigenic lymphoid cells using 1H 2-D COSY NMR spectroscopy.
    Tang HL; Buist RJ; Rixon RH; Whitfield JF; Smith IC
    NMR Biomed; 1992; 5(2):69-74. PubMed ID: 1320392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assignment of resonance in the 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy.
    Behar KL; Ogino T
    Magn Reson Med; 1991 Feb; 17(2):285-303. PubMed ID: 1676483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells.
    Lean CL; Mackinnon WB; Delikatny EJ; Whitehead RH; Mountford CE
    Biochemistry; 1992 Nov; 31(45):11095-105. PubMed ID: 1445848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?
    Louis E; Adriaensens P; Guedens W; Vanhove K; Vandeurzen K; Darquennes K; Vansteenkiste J; Dooms C; de Jonge E; Thomeer M; Mesotten L
    Ann Oncol; 2016 Jan; 27(1):178-84. PubMed ID: 26487580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR in cancer: XX. FONAR scans of patients with cancer.
    Damadian R; Goldsmith M; Minkoff L
    Physiol Chem Phys; 1978; 10(3):285-7. PubMed ID: 216040
    [No Abstract]   [Full Text] [Related]  

  • 10. 2D-Cosy NMR Spectroscopy as a Quantitative Tool in Biological Matrix: Application to Cyclodextrins.
    Dufour G; Evrard B; de Tullio P
    AAPS J; 2015 Nov; 17(6):1501-10. PubMed ID: 26304859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of protein bound serum fucose in cancer of the breast.
    Hadjivassiliou A; Castanaki A; Hristou G; Lissaios B
    Surg Gynecol Obstet; 1975 Feb; 140(2):239-40. PubMed ID: 1124474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma.
    Tang H; Wang Y; Nicholson JK; Lindon JC
    Anal Biochem; 2004 Feb; 325(2):260-72. PubMed ID: 14751261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fucose in the diagnosis of breast cancer.
    Rosato FE; Seltzer M; Mullen J; Rosato EF
    Cancer; 1971 Dec; 28(6):1575-9. PubMed ID: 5127806
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen and L-fucose in malignant and benign mammary disease.
    Wilkinson EJ; Hause LL; Sasse EA; Pattillo RA; Milbrath JR; Lewis JD
    Am J Clin Pathol; 1980 May; 73(5):669-75. PubMed ID: 7377133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fucosylation of serum proteins in stomach cancer].
    Sorkin VM; Borisenko SN; Kasymova GA
    Vopr Med Khim; 1987; 33(4):49-52. PubMed ID: 3660739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS
    Chen W; Lu S; Wang G; Chen F; Bai C
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e232-e238. PubMed ID: 27670847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum protein-bound fucose and carcinoma of the female breast.
    Rosato FE; Seltzer MH
    Am J Surg; 1969 Jul; 118(1):61-4. PubMed ID: 5794052
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors.
    Kriat M; Vion-Dury J; Confort-Gouny S; Favre R; Viout P; Sciaky M; Sari H; Cozzone PJ
    J Lipid Res; 1993 Jun; 34(6):1009-19. PubMed ID: 8354948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.